Milestone Pharmaceuticals Inc. Common Shares (MIST) Stock Price, Quote & AI Analysis

Live MIST stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Milestone Pharmaceuticals Inc. Common Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Milestone Pharmaceuticals Inc. Common Shares (MIST), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

MIST
Milestone Pharmaceuticals Inc. Common Shares
real-time
$0.00 +0.00 (+0.00%)
Open
1.670000
High
1.740000
Low
1.645000
Volume
1,517,395
VWAP
-
Market Cap
$143,084,497.92
52W Range
$0.63 - $3.06
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 11, 2026 Q4
After Hours
EPS Estimate: $-0.1632
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Milestone Pharmaceuticals Inc. Common Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Milestone Pharmaceuticals Inc. Common Shares Overview

Company information

Company Overview

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications. The company was founded by Philippe Douville and Philippe Lamarre in 2003 and is headquartered in Montreal, Canada.

Company Details
Market Cap
$144.36M
Shares Outstanding
85,169,339
Weighted Shares Outstanding
85,169,344
CEO
Joseph G. Oliveto
Address
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, A8, H4M 2X6
Employees
33
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Milestone Pharmaceuticals Inc. Common Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...